-
-
-
-
Manufacturing
-
PRODUCT CENTER
To date, Qilu has launched over 300 products with over 55 products “First-to- launch” in China. The company has also fostered a robust pipeline including over 200 generic products, 80 innovative products, and 20 biosimilars.
-
FINISHED DOSAGE FORMS
Leading injectable and solid dose manufacturer with significant in-house development and manufacturing capabilities.Click to view + -
ACTIVE PHARMACEUTICAL INGREDIENTS
Equipped with large-scale manufacturing facilities for the production of chemically synthesized, lyophilized, sterile, crystallized and fermented APIs.Click to view +
ABOUT US
Originated from QILU, Universal love to the WORLD
Qilu Pharmaceutical is one of the leading vertically integrated pharmaceutical companies in China focusing on the development, manufacturing and marketing of active pharmaceutical ingredients (APIs) & finished formulations. Qilu currently has 12 subsidiaries, 11 manufacturing sites and over 39,000 employees worldwide, 70% of whom are with bachelor’s degree or above. Qilu ranks among Top 3 in Chinese pharmaceutical industry in 2023. Dedicated to offering more affordable medicines to the world and improving people's well-being, Qilu has exported its products to over 100 countries.
Qilu Pharmaceutical has always maintained an innovative development strategy guided by the market demand and is achieving its organic growth strategy utilizing a strong pool of over 5,000 scientists spreading across 6 R&D platforms based in the US (Seattle WA, Boston MA, San Francisco CA) and China (Shanghai, Jinan, Hainan). To date, Qilu has launched over 300 products with over 55 products “First to launch” in China and 3 products “D181 launch”in US. The company has also a robust pipeline, including over 200 generic products, over 30 biosimilar products and over 90 innovative products.
EXPLORE MORE >>Domestic Manufacturing Sites
Chinese Pharma. & Industrial Enterprise
Employees
Marketed Products
R & D
Our Capabilities
Focusing on the research and development of generic and innovative drugs, Qilu Pharmaceutical has formed a complete innovative development system covering early stage discovery...
Partnerships
At Qilu, we believe communication and collaboration are key to success and we are always open for different cooperative models and opportunities, especially license and co-development opportunities in the following areas:
NEWS
0531-83126666 
wangzhan@qilu-pharma.com 
Tel: +86-531-83127705, 83127704, 83127706, 83127711
Address: 8888 Lvyou Road, High-tech Zone, Jinan, 250104, China
E mail：export@qilu-pharma.com, FDF@qilu-pharma.com
监督举报
亲爱的合作伙伴：
欢迎举报以下行为！
索贿、暗箱操纵招标、内定中标单位、员工或亲属参与公司业务往来牟取私利、偷工减料、以次充好、故意刁难供应商等行为。
举报电话：0531-83126898/55820713/83126871
举报邮箱：qljc@qilu-pharma.com
收信地址：山东省济南市历城区旅游路8888号
齐鲁制药集团审计监察部
采购平台技术专线